Current Affairs - February 2022 The Government of India is committed to becoming a net-zero carbon emitter by which year? 2070 2030 2050 2060 2070 2030 2050 2060 ANSWER EXPLANATION DOWNLOAD EXAMIANS APP The government is committed to increasing the share of non-fossil fuels by 2030 and becoming a net-zero emitter by 2070.
Current Affairs - February 2022 Who is the winner of the AFC Women`s Asian Cup India 2022? China PR South Korea India Japan China PR South Korea India Japan ANSWER EXPLANATION DOWNLOAD EXAMIANS APP China PR has won the AFC Women`s Asian Cup India 2022 final title and defeated South Korea (Korea Republic), 3-2.
Current Affairs - February 2022 Which bank has partnered with Assam Rifles to provide Central Forces Salary Package to all personnel of the force? Bank of Baroda State Bank of India Union Bank of India Punjab National Bank Bank of Baroda State Bank of India Union Bank of India Punjab National Bank ANSWER EXPLANATION DOWNLOAD EXAMIANS APP Bank of Baroda has signed an MoU with Assam Rifles, the oldest paramilitary force, to provide the Baroda Central Forces Salary Package to all personnel of the Assam Rifles.
Current Affairs - February 2022 Which nation's Prime Minister is likely to visit Russia on the first trip in 23 years? China North Korea Bangladesh Pakistan China North Korea Bangladesh Pakistan ANSWER EXPLANATION DOWNLOAD EXAMIANS APP Pakistan's Prime Minister Imran Khan is likely to visit Russia later this month in the first such trip by a Pakistani prime minister in 23 years.
Current Affairs - February 2022 What is the current rate of Marginal Standing Facility? 4.55% 4.35% 4.00% 4.25% 4.55% 4.35% 4.00% 4.25% ANSWER EXPLANATION DOWNLOAD EXAMIANS APP The current Marginal Standing Facility Rate is 4.25%.
Current Affairs - February 2022 Spikevax, which received full approval from US FDA, was manufactured by which pharma company? Moderna Pfizer Astrazeneca Johnson and Johnson Moderna Pfizer Astrazeneca Johnson and Johnson ANSWER EXPLANATION DOWNLOAD EXAMIANS APP Moderna's Covid-19 vaccine named 'Spikevax' has received full approval from the US Food and Drug Administration, for use in people ages 18 and older.